trimethoprim enhances the in vitro activity of nalidixic and oxolinic acids against some representative pathogenic microorganisms , including those which are most frequently responsible for urinary tract infections , and delays the emergence of resistance in many of them .
C0041041
trimethoprim
C0042029
urinary tract infections